Additional file 8: of Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Heat maps for core enrichment genes from transforming growth factor beta receptor (TGFBR) ( A ) and platelet-derived growth factor receptor beta (PDGFRB) ( B ) signaling pathways corresponding to Fig.  5 . (PDF 316 kb)